companies; (5) derivatives intermediary ; (6) life insurance companies; (7) non-life insurance companies; (8) mutual funds; (9) private funds; (10) provident funds; (11) Government Pension Fund; (12) Social
intermediary; (6) life insurance companies; (7) non-life insurance companies; (8) mutual funds; (9) private funds; (10) provident funds; (11) Government Pension Fund; (12) Social Security Fund; (13) listed
แห่งหนี้ใน Benchmark Bond Index ซึ่งในการพิจารณาคัดเลือกตราสาร ได้มีการคำนึงถึงสภาพคล่องของตราสารแล้ว เช่น JP Morgan World Government Bond Index (13) ธุรกรรมการซื้อโดยมีสัญญาขายคืนที่มีอายุคงเหลือไม่เกิน
รัฐบาล (Government Bond) 207 พันธบัตรรัฐวิสาหกิจ (State Owned Enterprise Bond) 209 พันธบัตรธนาคารแหงประเทศไทย (BoT Bond) 210 พันธบัตรหรือตราสารหนี้ที่ FIDF เปนผูออก ผูรับรอง ผูอาวัล ผูค้ําประกัน 211
, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the
domestic demand continued to expand driven mainly by improving of agricultural sector and government measures to support low-income households. As of May 31, 2019, the Company’s total cards reached 8.63
Ayudhaya (BAY) and Government Saving Bank (GSB) and add new interesting services continuously i.e. lottery by bank. Moreover, the Company focus on expanding the Smart Boonterm kiosk that sells SIM Card with
at key customers. These issues are resolved and with expected fixed asset investment due to the expected government stimulus and a new product, targeting steel customers, now ready this part of the
including the recovery of investment signals in new projects and government spending. These are the economic stimulus that benefited the customers of the Company and its subsidiaries in various industries and